Financials in USD. Standardized financial statements.
A compact view of how Ventana Biotech, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $114,577 | $41,362 | $31,845 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth? | +177.0% | +29.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $0 | $41,362 | $31,845 | $0 | $0 | $0 | $3,472 | $0 |
| Gross Profit? | $0 | $0 | $0 | $0 | $0 | $0 | -$3,472 | $0 |
| Gross Margin? | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $13,762 | $20,567 | $13,380 | $6,975 | $300 | $600 | $39,649 | $164,054 |
| Operating Income? | $100,815 | $20,795 | $18,465 | -$6,975 | -$300 | -$600 | -$43,121 | -$164,054 |
| EBITDA? | $100,815 | $20,795 | $18,465 | -$6,975 | -$300 | -$600 | -$39,649 | -$164,054 |
| Income Before Tax | $100,940 | $20,762 | $18,465 | -$81,535 | -$5,224 | -$3,856 | -$47,082 | -$165,587 |
| Income Tax Expense | $14,801 | $872 | $1,182 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | $86,139 | $19,890 | $17,283 | -$81,535 | -$5,224 | -$3,856 | -$47,082 | -$165,587 |
| EPS? | $0.00 | $0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.02 | $-0.00 |
| Diluted EPS? | $0.00 | $0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.02 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality